The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen ...

While the pharmaceutical industry is heavily regulated to ensure medication safety, these regulations should not hinder ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...

J&J said its latest bankruptcy bid is backed by around 83% of the 60,000-plus claimants cited in lawsuits, who are claiming ...

UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the ...

Zevra Therapeutics' Miplyffa has become the first medicine to be approved by the FDA for the ultra-rare genetic disorder ...

Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...

J&J's high expectations for Rybrevant are driven mainly by its August approval with Lazcluze, which outperformed Tagrisso in ...

The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...

Global events can pose significant challenges to the supply of APIs, and thus the continuity of drug supply. Any disruption ...

Astellas is ready to launch its first digital health offering in the US, a toolkit dedicated to providing at-home monitoring ...